Nova Eye Medical (EYE) Discussion, page-2353

First 2353 Last

Share
Profile

Follow
bar

739 Posts.

118

22/02/24

14:47

Post #: 72538645
Share

Originally posted by TheAnalyst007: ↑

Yeah I would say it is. It would be sort of pointless to establish a favourite stock with a long-term bias only to switch to a different stock as soon as there is a bit of pessimism in the market. Periods of short term pain and pessimism in markets are inevitable. The key in my view is being able to see the opportunity during these periods, rather than running away from it in fear, and backing your calls through the ups and downs. I remember immediately following the LCD news in late December, so many posters here were commenting about how they had wished they saw through the pessimism and loaded up at the lows. I wouldn't be surprised if the same happens again, a bit of pessimism that will immediately turn into optimism as soon as that big 2RT announcement arrives. A day later, like clockwork, everyone will be wishing they had bought at 21c lol.

Fundamentally, the company is doing really well. They have focused their limited resources on the US market and delivered strong performance in that market, with 65% growth despite the negative pressure of the LCD. Global wasn't fantastic, but they did clearly say they were going to focus on the US market. I don't think anyone should have expected much growth outside of the US. Now for the first time they have confirmed a near term date by which they will be cash flow positive, and with the recent CR they will be able to begin allocating more resources to the rest of the world. So fundamentally I would say things are very sound. On the cap raise front, no one likes dilution, but those funds are being entirely used to fund further growth, so it should be quite accretive in the longer term.

The market will be pessimistic for a bit longer I'm sure, but in my view the company is stronger than ever. So when you ignore the recent price action, I would say things have only really improved. The company is growing fast and now has a big pile of cash to play with. At only a $ 50m market cap, there is certainly plenty of upside here IMO.

Expand

The fact that there is a CR does that indicate that a 2RT announcement is 3 months or more off, i.e. directors buying or does that not apply when the offer is open to shareholders as well.

EYE Price at posting: 21.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

What's causing the cost-of-living crisis, and how to navigate it

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk